(5-(methyl-d3)-6-(propyl-d7)pyridin-3-yl)boronic acid
95%
- Product Code: 91349
CAS:
2241876-05-9
Molecular Weight: | 189.08557778 g./mol | Molecular Formula: | C₉H₄BD₁₀NO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃, sealed and dry |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of deuterated drugs. Its deuterated structure enhances the metabolic stability of potential drug candidates, making it valuable in the creation of compounds with improved pharmacokinetic profiles. It serves as a key intermediate in the preparation of labeled analogs for use in drug discovery, enabling the study of drug metabolism and distribution through isotopic tracing. Additionally, it is employed in cross-coupling reactions, such as Suzuki-Miyaura coupling, to construct complex molecules for medicinal chemistry applications. Its use in these reactions contributes to the development of novel therapeutic agents with enhanced efficacy and safety.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿269,620.00 |
+
-
|
0.025 | 10-20 days | ฿720,000.00 |
+
-
|
(5-(methyl-d3)-6-(propyl-d7)pyridin-3-yl)boronic acid
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of deuterated drugs. Its deuterated structure enhances the metabolic stability of potential drug candidates, making it valuable in the creation of compounds with improved pharmacokinetic profiles. It serves as a key intermediate in the preparation of labeled analogs for use in drug discovery, enabling the study of drug metabolism and distribution through isotopic tracing. Additionally, it is employed in cross-coupling reactions, such as Suzuki-Miyaura coupling, to construct complex molecules for medicinal chemistry applications. Its use in these reactions contributes to the development of novel therapeutic agents with enhanced efficacy and safety.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :